Telomir Pharmaceuticals holds annual shareholder meeting

PUBT · 1d ago
Telomir Pharmaceuticals holds annual shareholder meeting
  • Telomir Pharmaceuticals held its 2026 annual shareholder meeting on Sept. 11, 2026.
  • Shareholders backed the appointment of Salberg & Company, P.A. as independent auditor for the year ending Dec. 31, 2026.
  • Votes also supported selecting four directors to serve until the next annual meeting.
  • Investors authorized an adjournment if needed to solicit additional proxies to secure support for the director slate and auditor item.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Telomir Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-042926), on September 16, 2026, and is solely responsible for the information contained therein.